Navigation Links
'Judging Edward Teller'
Date:10/25/2010

wentieth century will be judged." Hecker adds, "He brings to life both the charming and dark sides of Edward Teller I witnessed during my years at Los Alamos."

Drawing for the first time on hitherto unknown archival material from Hungarian, American, and German sources, Hargittai provides fresh insights that help the reader to understand Teller's motivations, his relationships with friends and foes, and his driven personality. In addition to this research and his own memories of Teller, Hargittai interviewed such prominent figures as Richard Garwin, Freeman Dyson, George A. Keyworth, and Wendy Teller (Edward Teller's daughter), among others.

The author reviews the significant facets of Teller's life: his Jewish-Hungarian origins, forced emigrations, brilliance in science, and devotion to the defense of the United States. Hargittai discusses Teller's ruthless Machiavellism in achieving his goals, which included his pivotal role in the creation of the hydrogen bomb and the second weapons laboratory at Livermore, as well as his damaging testimony against physicist J. Robert Oppenheimer. Teller's peers viewed this testimony as a betrayal and, in effect, sent him into internal exile, which Hargittai describes as more tormenting to Teller than his previous emigrations. He notes that Teller was sometimes called "a monomaniac with many manias," such as his fierce opposition to nuclear test bans during the Cold War and, toward the end of his life, his role as propagandist for the Strategic Defense Initiative. Yet, his very excesses may have in fact contributed to the demise of the Soviet Union.

Harold M. Agnew, former director of Los Alamos National Laboratory and former chairman of the US General Advisory Committee ACDA calls JUDGING EDWARD TELLER "a must read for those who wish an accurate accounting of Teller and his associates who led the free world into the nuclear era."

So who was Edward Tellerthe real "Dr. Strangelove," the drive
'/>"/>

Contact: Jill Maxick
jmaxick@prometheusbooks.com
800-853-7545
Prometheus Books
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Governments misjudging scale of CO2 emissions
2. Nobel Prize for Professor Robert G. Edwards, Editor Emeritus of Reproductive BioMedicine Online
3. Robert Edwards, a founder of ESHRE, honored as Nobel laureate
4. Study shows woody plant encroachment has increased stream flow in the Edwards Plateau
5. Arthritis Foundation of India Trust named winner of 2009 IOF Linda Edwards Memorial Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Judging Edward Teller'
(Date:7/8/2015)... SAN DIEGO , July 8, 2015 /PRNewswire/ ... of cell-free molecular diagnostics, today announced the launch ... of the Company,s Precision Cancer Monitoring℠ (PCM) technology ... patients receiving one or a combination of the ... and Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient ...
(Date:7/7/2015)... July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... growing mobile commerce market announces a revised version of one of ... commercial will air on CNBC in New York ... and San Francisco metro areas.    ... on Wocket,s ability to replace all the cards in your wallet ...
(Date:6/30/2015)... 30, 2015 To bolster its efforts and commitment ... announced today the addition of two new team members. ... advisor and David Raviv will act as head ... Corp.,s commitment to providing the most secure solutions for the ... co-founded Layer 7 Technologies, a provider of security and management ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... A major initiative to create alternative nesting sites for the ... help protect juvenile salmon and steelhead in the Columbia River ... nesting site at Crump Lake in southern Oregon, which was just ... more than 135 nesting pairs of Caspian terns, as well as ...
... called for Europe to invest more funds into the study ... role in the function of human cells and which are ... to Alzheimer,s. Common lipids such as cholesterol are known ... cells and tissues, but human cells contain thousands of different ...
... Belfast is appealing for help from the public in looking ... Activities such as aquaculture, shipping and recreational boating have led ... Now Queen,s is attempting to find out exactly where and how ... this it is asking for help from the public to record ...
Cached Biology News:Project succeeding to relocate Caspian terns 2Project succeeding to relocate Caspian terns 3Project succeeding to relocate Caspian terns 4Project succeeding to relocate Caspian terns 5Project succeeding to relocate Caspian terns 6Europe-wide investment in lipid research will help tackle disease, says new report 2Queen's marine biologist investigates aliens beneath the waves 2
(Date:7/31/2015)... ... ... R-Biopharm is proud to announce the RIDASCREEN® Gliadin Competitive ... been accepted by AOAC International as Official First Action method. The AOAC Official ... R5 Competitive ELISA,” based on a specific monoclonal antibody to potentially celiac toxic ...
(Date:7/30/2015)... ATLANTA , July 30, 2015 ... leaders to the 2015 AACC Annual Meeting & ... from July 26–30. The meeting showcased revolutionary ... improves the ability of healthcare providers to diagnose ... get effective medical treatment. As ...
(Date:7/30/2015)... USA (PRWEB) , ... July 30, 2015 , ... ... microsystems, has appointed Francois Vieillard as Sales & Marketing Director. , With ... Francois Vieillard will be responsible for reinforcing Tronics’ business development activities worldwide. He ...
(Date:7/30/2015)... According to a new market ... PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), ... by End Users - Global Forecast to 2020", published ... USD 2,107.99 million by 2020 from USD 1,034.93 million ... Browse more than 75 ...
Breaking Biology Technology:RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Tronics appoints Francois Vieillard as Sales and Marketing Director 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4
... N.Y., March 20 XTL,Biopharmaceuticals Ltd. (Nasdaq: ... pre-clinical program in Hepatitis C focused on the ... Inc. Presidio,is a private biotechnology company focused on ... backed by some of the,most prominent investors in ...
... Corporation, a leading,provider of fully integrated imaging ... of its real-time patient and resource,scheduler software, ... staff, rooms with drag and drop ease,delivering ... ROI., A free CardioSchedule Information Kit ...
... March 20 Amsterdam Molecular,Therapeutics (Euronext: AMT), a ... announced that AMT,s Supervisory Board has decided to ... Board at its Annual,General Meeting of shareholders on ... of TomTom (Euronext Amsterdam: TOM2), and has been,instrumental ...
Cached Biology Technology:XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals 2XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals 3XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals 4LUMEDX Updates Real-Time Patient and Resource Scheduler for Healthcare Systems 2Amsterdam Molecular Therapeutics to Appoint Alexander Ribbink to Supervisory Board 2Amsterdam Molecular Therapeutics to Appoint Alexander Ribbink to Supervisory Board 3
...
... antibody-based immunoaffinity matrices, such as Sepharose ... without compromising antigen-antibody reactivity, the need ... has precluded the application of these ... CHEMICON Re-Blot Plus Western Blot Mild ...
Applications: Western blotting ...
Applications: Western blotting ...
Biology Products: